VEGF inhibitor PTC299
CDR0000680634
Phase 1 small_molecule completed
Quick answer
VEGF inhibitor PTC299 for Brain and Central Nervous System Tumors is a Phase 1 program (small_molecule) at PTC THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PTC THERAPEUTICS, INC.
- Indication
- Brain and Central Nervous System Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed